Lian Brian — SEC Form 4 filings

SEC reporting owner CIK 1614578. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-01-30 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Viking Therapeutics, Inc. (VKTX)President & CEO, Director1528 legs · 1,522,232 sh · $64,057,01530

Form 4 filings — Lian Brian

FiledFormIssuerReported transactionsSource
2026-07-294Viking Therapeutics, Inc. (VKTX)Grant/award (A): 221,667 @ $0 · Sale (S): 148,517 @ $33.32EDGAR
2026-01-054Viking Therapeutics, Inc. (VKTX)Grant/award (A): 78,400 @ $0 · Grant/award (A): 224,080 @ $0 · Sale (S): 132,454 @ $32.29 · Sale (S): 53,279 @ $33.38 · Sale (S): 41,276 @ $34.22 · Sale (S): 6,400 @ $35.07 · +1 moreEDGAR
2025-10-284Viking Therapeutics, Inc. (VKTX)Grant/award (A): 70,084 @ $0 · Sale (S): 38,989 @ $35.01EDGAR
2025-07-034Viking Therapeutics, Inc. (VKTX)Grant/award (A): 48,333 @ $0 · Sale (S): 26,889 @ $27.80EDGAR
2025-01-064Viking Therapeutics, Inc. (VKTX)Grant/award (A): 92,800 @ $0 · Grant/award (A): 163,333 @ $0 · Sale (S): 175,490 @ $42.68 · Sale (S): 19,000 @ $43.32 · Grant/award (A): 78,300 (derivative) @ $0EDGAR
2024-09-204Viking Therapeutics, Inc. (VKTX)Option exercise (M): 166,130 @ $7.77 · Sale (S): 96,056 @ $70.43 · Sale (S): 119,874 @ $71.15 · Sale (S): 200 @ $71.98 · Option exercise (M): 166,130 (derivative) @ $0EDGAR
2024-08-224Viking Therapeutics, Inc. (VKTX)Option exercise (M): 1,000 @ $7.77 · Sale (S): 1,000 @ $69.90 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2024-08-194Viking Therapeutics, Inc. (VKTX)Option exercise (M): 112,870 @ $7.77 · Sale (S): 70,132 @ $65.33 · Sale (S): 31,442 @ $66.37 · Sale (S): 11,296 @ $67.12 · Option exercise (M): 112,870 (derivative) @ $0EDGAR
2024-07-314Viking Therapeutics, Inc. (VKTX)Grant/award (A): 41,000 @ $0 · Grant/award (A): 163,333 @ $0 · Sale (S): 65,941 @ $56.95 · Sale (S): 19,501 @ $57.81 · Sale (S): 30,417 @ $58.78EDGAR
2024-03-274Viking Therapeutics, Inc. (VKTX)Grant/award (A): 221,667 @ $0 · Tax withholding (F): 153,948 @ $83.34EDGAR
2024-03-044Viking Therapeutics, Inc. (VKTX)Grant/award (A): 221,667 @ $0 · Tax withholding (F): 162,815 @ $85.22EDGAR
2024-02-094Viking Therapeutics, Inc. (VKTX)Sale (S): 45,000 @ $29.90EDGAR
2024-02-084Viking Therapeutics, Inc. (VKTX)Option exercise (M): 49,079 @ $1.23 · Sale (S): 49,079 @ $25.75 · Option exercise (M): 140,000 @ $4.65 · Sale (S): 60,000 @ $25.95 · Sale (S): 80,000 @ $26.95 · Sale (S): 40,000 @ $27.45 · +4 moreEDGAR
2024-01-314Viking Therapeutics, Inc. (VKTX)Option exercise (M): 85,000 @ $1.23 · Sale (S): 40,000 @ $24.45 · Sale (S): 45,000 @ $24.95 · Option exercise (M): 85,000 (derivative) @ $0EDGAR
2024-01-304Viking Therapeutics, Inc. (VKTX)Option exercise (M): 35,000 @ $1.23 · Sale (S): 35,000 @ $23.95 · Option exercise (M): 35,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614578 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →